Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$72.62 - $79.98 $690,107 - $760,049
-9,503 Closed
0 $0
Q1 2022

Apr 14, 2022

SELL
$61.48 - $73.72 $2,151 - $2,580
-35 Reduced 0.37%
9,503 $694,000
Q4 2021

Jan 28, 2022

SELL
$53.63 - $62.52 $40,115 - $46,764
-748 Reduced 7.27%
9,538 $595,000
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $7,041 - $8,247
-119 Reduced 1.14%
10,286 $609,000
Q2 2021

Aug 11, 2021

SELL
$61.91 - $67.42 $1,485 - $1,618
-24 Reduced 0.23%
10,405 $695,000
Q1 2021

May 06, 2021

SELL
$59.34 - $66.74 $1.52 Million - $1.71 Million
-25,571 Reduced 71.03%
10,429 $658,000
Q4 2020

Feb 09, 2021

SELL
$57.74 - $65.43 $3.39 Million - $3.84 Million
-58,627 Reduced 61.96%
36,000 $2.23 Million
Q3 2020

Nov 02, 2020

SELL
$57.43 - $63.64 $1.16 Million - $1.28 Million
-20,187 Reduced 17.58%
94,627 $5.71 Million
Q2 2020

Aug 04, 2020

SELL
$54.82 - $64.09 $180,467 - $210,984
-3,292 Reduced 2.79%
114,814 $6.75 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $34,011 - $49,426
733 Added 0.62%
118,106 $6.58 Million
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $475,565 - $620,332
9,664 Added 8.97%
117,373 $7.53 Million
Q3 2019

Nov 07, 2019

BUY
$42.77 - $50.71 $4.61 Million - $5.46 Million
107,709 New
107,709 $5.46 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $168,173 - $218,080
-3,449 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $190,350 - $214,700
3,449 New
3,449 $214,000
Q2 2018

Aug 10, 2018

SELL
$50.53 - $62.98 $5.29 Million - $6.59 Million
-104,708 Closed
0 $0
Q1 2018

May 07, 2018

BUY
$59.92 - $68.98 $5.71 Million - $6.57 Million
95,269 Added 1009.31%
104,708 $6.62 Million
Q4 2017

Feb 12, 2018

SELL
$59.94 - $65.35 $11,988 - $13,069
-200 Reduced 2.07%
9,439 $578,000
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $532,361 - $614,389
9,639
9,639 $614,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bar Harbor Trust Services Portfolio

Follow Bar Harbor Trust Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bar Harbor Trust Services, based on Form 13F filings with the SEC.

News

Stay updated on Bar Harbor Trust Services with notifications on news.